Multiple Myeloma

Multiple myeloma is a blood cancer of plasma cells that live in the bone marrow. Abnormal (“clonal”) plasma cells make a monoclonal protein (M-protein) and can damage bone, kidneys, and blood counts. There is no routine population screening; myeloma is often suspected after symptoms or an abnormal complete blood count (CBC) or protein test are found. Diagnosis relies on specific blood, urine, bone marrow, and imaging studies interpreted by a clinician.

Closely related conditions include MGUS (monoclonal gammopathy of undetermined significance) and smoldering multiple myeloma (SMM)—states with a monoclonal protein but without “myeloma-defining events.” The International Myeloma Working Group (IMWG) diagnostic criteria include classic CRAB features (hyperCalcemia, Renal impairment, Anemia, Bone lesions) and validated biomarkers (the SLiM criteria) that identify very-high-risk SMM needing treatment.


Signs & Symptoms (When to consider testing)

  • Bone & spine: persistent back/hip/rib pain, fractures after minimal trauma, height loss.

  • Blood & energy: anemia (fatigue, shortness of breath), frequent infections.

  • Kidney & chemistry: foamy/dark urine, swelling, elevated creatininehigh calcium (thirst, constipation, confusion).

  • Neurologic: numbness/tingling, weakness (compression fractures or hyperviscosity).

  • Incidental clues: high total protein, abnormal SPEP or light chains on blood work.
    Urgent care is needed for severe pain, confusion, dehydration, fever ≥100.4°F (38°C), or breathing difficulty.


Why These Tests Matter

What myeloma testing can do

  • Confirm a monoclonal protein and quantify it (SPEP/UPEP with immunofixationserum free light chains).

  • Identify myeloma-defining events: CRAB features and SLiM biomarkers (≥60% clonal marrow plasma cells; involved/uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L; >1 MRI focal lesion ≥5 mm).

  • Stage risk (e.g., R-ISS / R2-ISS) using β2-microglobulin, albumin, LDH, and high-risk cytogenetics.

  • Establish baselines for monitoring response and minimal residual disease (MRD) with standardized methods.

What these tests cannot do

  • Replace a full clinical evaluation or imaging when symptoms suggest complications.

  • Diagnose by a single abnormal result—patterns across tests, plus bone marrow and imaging, are required.


What These Tests Measure (at a glance)

Monoclonal protein detection & quantification

  • SPEP (serum protein electrophoresis) and immunofixation: detect and type the M-protein.

  • sFLC (serum free light chains): measures kappa/lambda light chains; critical in light-chain myeloma.

  • Urine studies (24-hour UPEP/IFE): quantify Bence Jones protein; still recommended by IMWG for full assessment and many response criteria.

General labs & staging

  • CBC (anemia), CMP (creatinine, calcium, liver function), β2-microglobulinLDHalbumin—inputs for R-ISS/R2-ISS staging.

Bone marrow & genetics

  • Bone marrow biopsy/aspirate with flow cytometrycytogenetics/FISH (e.g., del(17p), t(4;14), t(14;16), 1q gain) for classification and risk.

Imaging (bone & marrow)

  • Whole-body low-dose CT (WBLDCT) is now first-line to detect lytic bone disease; whole-body MRI and FDG-PET/CT are complementary and used per IMWG guidance. Conventional skeletal survey is less sensitive and generally a fallback.

Response/monitoring

  • IMWG response criteria (CR, VGPR, PR, etc.) integrate serum/urine M-protein and bone marrow.

  • MRD by next-generation flow or sequencing (typical sensitivity 10?5 or deeper) can refine prognosis and track deep response.


How the Testing Process Works

  1. Initial labs (ordered by your clinician): CBCCMP (calcium/creatinine)SPEP/IFEsFLC, and 24-hour urine(UPEP/IFE) to confirm and quantify monoclonal protein.

  2. ImagingWBLDCT at baseline; MRI and/or PET-CT based on findings and availability.

  3. Bone marrow studies: biopsy with flow cytometrycytogenetics/FISHmolecular tests for risk and classification.

  4. Follow-up: staging (R-ISS/R2-ISS) and a monitoring plan (IMWG response ± MRD in appropriate settings).


Interpreting Results (general guidance)

  • Myeloma-defining events: CRAB features or SLiM biomarkers confirm active myeloma and generally prompt treatment (per clinician).

  • MGUS/SMM: monoclonal protein or clonal plasma cells without MDEs; require risk-adapted surveillance—not population screening.

  • StagingR-ISS uses β2-microglobulin, albumin, LDH, and high-risk cytogenetics; R2-ISS further refines risk (e.g., incorporating 1q gain, additive cytogenetics) for prognosis.

  • MRD: sustained MRD-negativity (serial assessments) is associated with improved outcomes, but results must be interpreted in full clinical context.

All results should be interpreted with a hematology/oncology professional.


Choosing Panels vs. Individual Tests

  • First look when myeloma is suspectedCBC, CMP (calcium/creatinine), SPEP/IFE, sFLC, 24-hr UPEP/IFE, plus WBLDCT.

  • Classification & riskBone marrow with flowFISH/cytogenetics; calculate R-ISS/R2-ISS.

  • Monitoring: serial SPEP/IFEsFLC, urine as applicable; apply IMWG response criteria; consider MRD where appropriate.


FAQs

Is there a screening blood test for multiple myeloma?
No. There are no recommended screening tests for people without symptoms. Myeloma is sometimes found early because a routine lab shows an abnormal protein or anemia.

What are the SLiM-CRAB criteria?
They’re myeloma-defining eventsS ≥60% clonal marrow plasma cells; Li—involved/uninvolved free light-chain ratio ≥100 with involved FLC ≥100 mg/L; M>1 MRI focal lesion ≥5 mm; plus classic CRAB end-organ damage.

Why do I need a 24-hour urine collection?
IMWG still recommends 24-hr UPEP/IFE for baseline and many response criteria, especially for light-chain disease, even as serum free light chain testing has become central.

Which imaging test is best?
Whole-body low-dose CT is now the first-line study for bone disease; MRI and PET-CT add complementary information about marrow and active lesions.

What does R-ISS or R2-ISS mean?
They’re staging systems that combine labs and genetics to estimate risk and guide follow-up; R2-ISS is a newer refinement that improves prognostic stratification.


Internal Links & Cross-References

  • Cancer Screening Hub

  • Leukemia

  • Lymphoma

  •  Cancer & Tumor Marker Men’s Screening

  • Cancer & Tumor Marker Women’s Screening

  • Multi-Cancer Early Detection (MCED)

  • Key Lab Tests: SPEP/Immunofixation • Serum Free Light Chains • 24-Hour Urine Protein (UPEP/IFE) • CBC • CMP (Calcium/Creatinine) • β2-Microglobulin • LDH • Bone Marrow Biopsy & Flow Cytometry • FISH/Cytogenetics • Whole-Body Low-Dose CT • Whole-Body MRI • FDG-PET/CT • IMWG MRD (NGF/NGS)


References

  1. American Cancer Society. Can Multiple Myeloma Be Found Early? Updated February 28, 2025.

  2. Rajkumar SV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncology. 2014.

  3. NCCN Guidelines for Patients: Multiple Myeloma. Version 2025.

  4. Hillengass J, et al. International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncology. 2019.

  5. American Cancer Society. Tests for Multiple Myeloma. Updated February 28, 2025.

  6. Kumar S, et al. IMWG consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncology. 2016.

  7. Mohyuddin GR, et al. Performance of newer myeloma staging systems and the role of 1q gain; overview of R-ISS and R2-ISS. Blood Cancer Journal. 2024.

  8. D’Agostino M, et al. Second Revision of the International Staging System (R2-ISS) for multiple myeloma. Journal of Clinical Oncology. 2022.

  9. Reddy A, et al. Comparison of 24-hour versus random urine for Bence Jones protein quantification; IMWG and CAP recommend 24-hour collection. Pract Lab Med. 2021.

  10. International Myeloma Foundation. IMWG Criteria for the Diagnosis of Multiple Myeloma and related disorders (overview and patient summary). 2024–2025 updates.

Available Tests & Panels

Tip: Begin with SPEP/IFE + sFLC + CBC/CMP + 24-hr UPEP/IFE, then add imaging and bone marrow studies for full classification and staging.

  • Page
  • 1
  • of
  • 2
  • Total Rows
  • 31
Name Matches

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Blood Draw
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The CBC with H/H, RBC, Indices, WBC and Platelets Test evaluates overall blood health by measuring hemoglobin, hematocrit, red blood cell count, size and indices, white blood cell levels, and platelets. It helps detect anemia, infections, clotting disorders, and immune or bone marrow conditions. Frequently ordered in routine exams, this test supports diagnosis, monitoring of chronic disease, and assessment of general health.

Blood
Blood Draw
Also Known As: Complete Blood Count Test, Hemogram Test

The Lactate Dehydrogenase (LDH) Test measures LDH enzyme levels in blood to assess tissue damage and overall health. Elevated LDH may indicate conditions such as liver disease, heart attack, anemia, infections, or certain cancers, while low levels are uncommon. Doctors use this test to help diagnose disease, monitor treatment effectiveness, and track cell damage. It provides valuable insight into metabolic activity and organ function.

Blood
Blood Draw
Also Known As: LD Test, LDH Test, Lactic Acid Dehydrogenase Test

The Immunofixation Serum Test identifies abnormal proteins in the blood called monoclonal immunoglobulins, often linked to multiple myeloma, Waldenström macroglobulinemia, or other plasma cell disorders. Physicians use this test to detect, classify, and monitor abnormal antibody production. Results help confirm suspected conditions, assess disease progression, and guide ongoing management of disorders affecting immune system function.

Blood
Blood Draw

The Immunofixation (IFE) Urine test detects and characterizes monoclonal proteins (free light chains/M-proteins) excreted in urine to evaluate plasma cell and lymphoproliferative disorders. It supports workup of light-chain disease, multiple myeloma, Waldenström macroglobulinemia, and amyloidosis, and helps distinguish monoclonal from polyclonal free light chains seen with glomerular leak, infection, or inflammation.

Urine
Urine Collection
Also Known As: IFE Urine Test

The Total Immunoglobulins Panel measures IgA, IgG, and IgM levels to evaluate immune system function. Abnormal results may indicate immune deficiency, chronic infections, autoimmune disorders, or certain blood cancers. IgA helps protect mucous membranes, IgG provides long-term defense, and IgM is the body’s first response to infection. Doctors use this blood test to diagnose, monitor, and manage immune-related conditions and overall immune health.

Blood
Blood Draw

Most Popular

The Immunoglobulin E (IgE) Test measures IgE antibody levels in blood to evaluate allergic reactions, asthma, and immune response. Elevated IgE may indicate allergies to food, pollen, or other triggers, as well as eczema or parasitic infections. Doctors order this test to investigate symptoms like hives, sneezing, or wheezing and to guide allergy treatment. Results provide vital insight into immune health, allergic sensitivity, and overall diagnostic care.

Blood
Blood Draw
Also Known As: Immunoglobulin E Test, Immunoglobulin E Antibody Test, IgE Antibody Test

Most Popular

The Immunoglobulin G (IgG) Test measures IgG antibody levels in blood to assess immune system function and long-term response to infections. Low IgG may indicate immune deficiencies or recurrent infections, while high levels may signal chronic inflammation, autoimmune disease, or certain infections. Doctors use this test to evaluate unexplained illness, monitor immune disorders, or assess overall immunity. Results provide vital insight into immune health and disease management.

Blood
Blood Draw
Also Known As: Immunoglobulin G Test, Immunoglobulin G Antibody Test, IgG Antibody Test

Most Popular

The Immunoglobulin M (IgM) Test measures IgM antibody levels in blood to evaluate immune response and early defense against infections. High IgM may indicate recent or acute infections, autoimmune disease, or certain blood disorders, while low levels may suggest immune deficiency. Doctors order this test to investigate recurrent infections, unexplained inflammation, or suspected immune problems. Results provide vital insight into antibody health, immune status, and diagnostic care.

Blood
Blood Draw
Also Known As: Immunoglobulin M Test, Immunoglobulin M Antibody Test, IgM Antibody Test

Most Popular

The Immunoglobulin A (IgA) Test measures IgA antibody levels in blood to evaluate immune system health and mucosal defense in the respiratory and digestive tracts. Low IgA may indicate immune deficiency, celiac disease, or recurrent infections, while high levels may suggest autoimmune disorders, liver disease, or chronic inflammation. Doctors use this test to assess unexplained illness or immune imbalance. Results provide key insight into antibody function and overall immunity.

Blood
Blood Draw
Also Known As: Immunoglobulin A Test, Immunoglobulin A Antibody Test, IgA Antibody Test

The Protein Electrophoresis Random Urine Test analyzes protein distribution in a urine sample to detect abnormal monoclonal or polyclonal proteins. It helps evaluate multiple myeloma, kidney damage, and systemic disorders affecting protein metabolism. This test supports monitoring of urinary protein loss, renal impairment, and plasma cell disorders, offering valuable insight into overall kidney and immune health.

Urine
Urine Collection
Also Known As: UPEP Test

The Protein Total and Protein Electrophoresis Test with Scan measures total protein in blood and separates it into albumin and globulin fractions to evaluate liver, kidney, and immune function. The scan identifies abnormal protein patterns linked to multiple myeloma, Waldenström’s macroglobulinemia, or chronic inflammation. Doctors order this test for unexplained fatigue, weight loss, or anemia. Results support diagnosis, monitoring, and treatment planning.


Urine
Urine Collection

The Kappa/Lambda Light Chains, Free with Ratio Blood Test measures free kappa and lambda light chains, proteins produced by plasma cells, and calculates their ratio. Abnormal results may indicate multiple myeloma, light chain amyloidosis, or related plasma cell disorders. Doctors use this test with serum protein electrophoresis and immunofixation to detect, diagnose, and monitor disease progression or treatment response in patients with suspected blood cancers.

Blood
Blood Draw

The Kappa/Lambda Light Chains Free with Ratio Urine Test measures free immunoglobulin light chains and calculates the kappa/lambda ratio to assess abnormal protein production. This test helps detect and monitor plasma cell disorders such as multiple myeloma, light chain disease, and monoclonal gammopathy, providing insight into renal involvement and disease progression.

Urine
Urine Collection

Urine
Urine Collection

Random
Phlebotomist

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Blood
Blood Draw
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Calcium Micronutrient Test measures calcium levels in the blood to assess nutritional status and detect imbalances. Calcium is essential for strong bones and teeth, muscle contraction, nerve signaling, and heart function. This test helps identify deficiencies, excess, or issues with absorption and metabolism, supporting diagnosis and management of bone health, hormonal balance, and overall wellness.

Patient must be 18 years of age or older.
Blood
Blood Draw
Also Known As: Ca Test, Serum Calcium Test, Calcium Blood Test

The Calcium Test measures calcium levels in blood to assess bone health, parathyroid function, and metabolic balance. Abnormal levels may indicate bone disease, parathyroid disorders, kidney disease, or certain cancers. Both low and high calcium can cause muscle spasms, weakness, or irregular heartbeat. Doctors order this test to monitor osteoporosis, kidney stones, or endocrine disorders. Results provide essential insight into bone, nerve, and overall metabolic health.

Blood
Blood Draw
Also Known As: Ca Test, Serum Calcium Test, Calcium Blood Test

The Heavy Metals Micronutrients Blood Test Panel measures levels of arsenic, cadmium, cobalt, lead, and mercury to assess exposure and potential toxicity. These metals, found in the environment, food, or workplaces, can affect the nervous system, kidneys, bones, and overall health. This panel helps detect harmful accumulation, guide treatment, and monitor risks from environmental or occupational exposure.

Patient must be 18 years of age or older.

The Protein Total and Albumin Test measures overall protein levels and albumin, the main blood protein made by the liver. Abnormal levels may indicate liver disease, kidney disorders, malnutrition, or chronic inflammation. Doctors order this test for patients with swelling, fatigue, or abnormal lab results. Results provide critical insight into nutritional status, liver and kidney function, and help guide diagnosis and treatment of metabolic or chronic conditions.

Blood
Blood Draw


The Protein Total 12 Hour Urine with Creatinine Test evaluates protein and creatinine levels in timed urine collection to help detect kidney damage, filtration disorders, and systemic conditions. Elevated protein may indicate nephrotic syndrome, chronic kidney disease, or diabetes-related renal complications. This test aids in assessing kidney function, protein balance, and overall metabolic health.

Urine
Urine Collection

The Protein Total 24-Hour Urine with Creatinine Test measures the amount of protein and creatinine excreted in urine over 24 hours. Elevated protein levels may indicate kidney disease, diabetic nephropathy, hypertension, or other renal disorders. Doctors use this test to evaluate kidney function, detect proteinuria, and monitor treatment response. Combining protein and creatinine helps ensure accurate results, making it essential for assessing long-term kidney health.

Urine
Urine Collection

In 2021, approximately 34,920 adults in the United States will be diagnosed with multiple myeloma. 

Multiple myeloma is a rare blood cancer that is often fatal. But survival rates are improving steadily over time, and multiple myeloma tests are a huge reason for that.

Diagnosing multiple myeloma can be time-consuming and scary, but the more you know about myeloma and the testing involved, the easier it will be.

If you have signs and symptoms of multiple myeloma and want to know what's next, you're in the right place. Keep reading this guide to learn everything you need to know about multiple myeloma and multiple myeloma tests. 

What is Multiple Myeloma

Multiple myeloma is a blood cancer that forms in your plasma cells. Your plasma cells help fight infections by producing antibodies that can recognize germs and attack them. 

When you have multiple myeloma, your body begins to produce abnormal plasma cells. These plasma cells try to make antibodies just like your normal plasma cells do, and only the difference is these antibodies don't function normally. The abnormal antibodies are monoclonal proteins or M proteins.

You then start to accumulate these abnormal plasma cells and antibodies in your body, leading to multiple myeloma symptoms such as fatigue, bone lesions, and the lack of ability to fight infections.

Types of Multiple Myeloma

There are two main types of multiple myeloma, indolent multiple myeloma and active multiple myeloma. There are also different subtypes of myeloma, categorized by their chromosomal abnormalities.

Indolent multiple myeloma is sometimes called asymptomatic myeloma because it doesn't cause symptoms. For a diagnosis of indolent myeloma, you need to have 10% or more of the blood cells in your bone marrow made up of plasma cells, or an M protein level of 30 g/L or higher in your blood.

Different risk levels predict when indolent myeloma might turn into active myeloma. These risk levels are low, intermediate, and high-risk.

The next type is active multiple myeloma, also known as symptomatic multiple myeloma. People with active multiple myeloma will have symptoms of multiple myeloma along with any of the following:

  • 10% or more of the blood cells in your bone marrow are plasma cells
  • M protein in your blood or urine
  • Anemia, kidney failure, or hypercalcemia
  • A tumor in bone or soft tissue that contains myeloma cells
  • Osteolytic lesions

The Condition MGUS 

A monoclonal gammopathy of undetermined significance (MGUS) can be a precursor to developing multiple myeloma in the future. This is a condition where you have a high monoclonal protein count in your blood but no other symptoms.

Usually, MGUS doesn't cause problems, but it can develop into multiple myeloma. For this reason, if you have MGUS, you'll need to have regular checkups to be sure it doesn't progress. 

Risk factors for Multiple Myeloma

While cell mutations cause multiple myeloma, certain factors increase your risk of getting multiple myeloma like:

  • Old age, especially if you're older than 65
  • If you're male
  • If you're African American
  • If you have a sibling or parent with myeloma, your risk increases
  • If you're diagnosed with MGUS 

Causes of Multiple Myeloma

Researchers aren't entirely sure what causes multiple myeloma, but it seems to be related to DNA mutations that alter chromosomes and turn off genes that naturally suppress tumors.

Signs and Symptoms of Multiple Myeloma

Symptoms of multiple myeloma can vary, especially early in the disease process. When you do have symptoms, you can expect:

  • Bone pain around your spine or chest
  • Nausea and loss of appetite
  • Constipation
  • Fatigue
  • Weight loss
  • Extreme thirst
  • Mental fogginess
  • Weakness or numbness
  • Frequent infections
  • Elevated calcium levels

The most common symptoms of multiple myeloma are commonly referred to using the acronym CRAB.

C stands for elevated calcium levels from bones breaking down. R stands for renal (kidney) failure, which occurs from abnormal proteins in the kidneys. A stands for anemia which is caused by the abnormal plasma cells crowding out the healthy cells. And B stands for bone lesions that most commonly occur in the spine and ribs.

Complications of Multiple Myeloma

Multiple myeloma can cause your bones to become weaker, leading to multiple fractures. Myeloma also causes anemia, which means your body doesn't have enough red blood cells. 

You can also experience low platelets in your blood, making it more difficult for your blood to clot. You're also more susceptible to infections and low white blood cells, which weaken your immune system even further.

The M proteins in multiple myeloma can clog your kidneys, causing them not to filter out toxins like they usually would. The build-up eventually leads to kidney failure.

How is Multiple Myeloma Diagnosed

Diagnosing multiple myeloma often happens by accident when you have blood drawn for another reason. Your doctor will ask you questions like:

  • How long you have had symptoms?
  • Are your symptoms becoming worse over time?
  • Does anything improve your symptoms?
  • Does anything make them worse?

Your doctor will order diagnostic tests and blood work. Initial bloodwork typically includes a complete blood count to measure the cells in your blood and kidney function tests to check how your kidneys are functioning.

Other blood and urine tests will be ordered to check if your body is making monoclonal proteins, and if so, how much. 

More examinations include CT Scans and an MRI to check your bones for tumors or damage. And finally, a bone marrow biopsy will determine how many abnormal plasma cells are in your bone marrow.

Lab Tests For Multiple Myeloma

One of the first tests your doctor will order is a complete blood count. A complete blood count will show red blood cells and platelets and give an overall picture of how your immune system functions.

Next, your doctor will want to assess the overall health of your kidneys and other organs by checking a complete metabolic panel. This panel will check your kidney and liver function, as well as your calcium levels.

lactate dehydrogenase level (LDH) is checked as elevations in your LDH can point to certain cancers like myeloma.

Next, an immunofixation urine test (IFE) is useful in evaluating the number of monoclonal proteins that collect in your urine which is one of the main signs of myeloma.

Your doctor will also want to check the levels of your immunoglobulins by ordering an immunoglobulin panel (IgA, IgG, IgM). Elevations of these immunoglobulins are found in certain cancers like multiple myeloma.

total protein and electrophoresis is a blood test the measures specific proteins in the blood. In this test, proteins are separated by their electrical charge, and it's often used to detect if you have monoclonal proteins in your blood.

Other tests that help with the treatment, diagnosis, and type of myeloma you have include the kappa/lambda light chains lab test. This test measures how many immunoglobulin-free light chains you have. If these levels are high, you have what's called a light chain type of myeloma. The surface light chains test is another way to detect how many light chains are on the cell's surface.

beta-2-microglobulin lab test measures another protein made by abnormal myeloma cells. This protein in itself doesn't cause problems, but in multiple myeloma, high levels of this may indicate a poor prognosis.

FAQS about Multiple Myeloma

Common questions about multiple myeloma usually start with asking if there is a cure. There is no cure for multiple myeloma, but treatments are improving every day. Life expectancy is also increasing, now extending over five years past diagnosis. And some people beat the odds, living another 10 to 20 years or more.

Are you wondering what happens if you are diagnosed with indolent myeloma? The good news is you only have a 10% risk each year of it progressing to active multiple myeloma. And people can have indolent myeloma for many years and never need treatment.

Do you need to see a specialist who explicitly treats multiple myeloma? Yes, it's a good idea to find an oncologist who focuses on treating and researching multiple myeloma. Specialists have better knowledge of new research, treatments, and clinical trials.

Resources

A great resource to check out is the National Comprehensive Cancer Network. This network is not for profit and combines 31 cancer centers devoted to research and education. You can find updates on webinars, conferences, and updated multiple myeloma guidelines for patients on this site. 

Multiple Myeloma Tests at Ulta Lab Tests

Ulta Lab Tests offers highly accurate and reliable tests, allowing you to make the best decisions for your health. Wonder what is so amazing about Ulta Lab Tests? We offer:

  • Secure and confidential results
  • No need for any health insurance
  • No need for a physician's referral
  • Affordable pricing on all tests
  • A 100% satisfaction guarantee

Order your multiple myeloma lab tests today, and your results will be provided to you securely within 24 to 48 hours in most cases.

Take control of your health and order your tests from Ulta Lab Tests today!